National Cancer Waiting Times Monitoring Data Set Overview

Introduction:

The Cancer Reform Strategy (2007) introduced new and changed commitments in terms of service standards for cancer PATIENTS that must be met. A Review of Cancer Waiting Times Standards was carried out by the Department of Health and published alongside Improving Outcomes: A Strategy for Cancer (2011).

Following this review it was confirmed in Improving Outcomes: A Strategy for Cancer that:

“overall, cancer waiting time standards should be retained. Shorter waiting times can help to ease patient anxiety and, at best, can lead to earlier diagnosis, quicker treatment, a lower risk of complications, an enhanced patient experience and improved cancer outcomes. The current cancer waiting times standards will therefore be retained.”

This updated version of the National Cancer Waiting Times Monitoring Data Set supports the continued management and monitoring of the following waiting times:

Patient Pathway Scenarios:

The Patient Pathway Scenarios for the National Cancer Waiting Times Monitoring Data Set are to be used to manage the collection of data for all PATIENTS suspected of having, or diagnosed with cancer.

Cancer for the purpose of this data collection exercise is defined using the International Classification of Diseases (ICD) codes. Data for Patient Pathway Scenarios two to seven must be collected and transmitted as specified for all PATIENTS with a PRIMARY DIAGNOSIS within the range C00 to C97 or D05, or a secondary or metastatic disease linked to the original PRIMARY DIAGNOSIS (ICD) within this range (excluding categories relating to non-melanoma skin cancer).

A full list of the International Classification of Diseases (ICD) diagnosis codes the Cancer Waiting Times Database will accept is available at: Cancer Waiting Times.

When reporting patient records to the Cancer Waiting Times Database:

Transmission:

Security and Confidentiality:

Security and confidentiality information to accompany the collection of this information is available at: Cancer Waiting Times.

Further guidance: